We are live on
!
Find out more
IH
IFC Holdings Portfolio holdings
AUM
$1.45B
Turnover
19.03%
1-Year Est. Return
15.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.78%
1 Year Est. Return
+15.5%
3 Year Est. Return
+25.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$95.8M
(+15%)
Cap. Flow
+$80.5M
Cap. Flow
% of AUM
10.71%
Top 10 Holdings %
Top 10 Hldgs %
38.12%
Holding
408
New
36
Increased
233
Reduced
86
Closed
36
Avg Time Held
1.7
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$5.43M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$4.79M |
| 3 |
Home Depot
HD
|
+$4.67M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$4.3M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.04M |
| 2 |
American Airlines Group
AAL
|
+$2.38M |
| 3 |
Middleby
MIDD
|
+$2.28M |
| 4 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$2.13M |
| 5 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 70.76% |
| 2 | Financials | 4.52% |
| 3 | Healthcare | 4.22% |
| 4 | Consumer Staples | 3.62% |
| 5 | Consumer Discretionary | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Invesco S&P 500 Low Volatility ETF
SPLV
$7.26B
| $627K | 0.08% |
16,251
+188
| +1% | +$7.17K |
2013 Q2
10 quarters
|
|
177
State Street Energy Select Sector SPDR ETF
XLE
$43.9B
| $627K | 0.08% |
20,788
+2,976
| +17% | +$98K |
2013 Q2
10 quarters
|
|
178
Biogen
BIIB
$34.4B
| $620K | 0.08% |
2,021
+41
| +2% | +$11.8K |
2013 Q4
8 quarters
|
|
179
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.88B
| $618K | 0.08% |
69,651
+11,756
| +20% | +$106K |
2015 Q1
3 quarters
|
|
180
Kimberly-Clark
KMB
$35.1B
| $618K | 0.08% |
4,834
+1,623
| +51% | +$195K |
2013 Q2
10 quarters
|
|
181
First Trust Value Line Dividend Fund
FVD
$7.91B
| $612K | 0.08% |
25,681
+218
| +0.9% | +$5.22K |
2013 Q4
8 quarters
|
|
182
iShares Russell 1000 ETF
IWB
$48.7B
| $612K | 0.08% |
5,398
+1,008
| +23% | +$115K |
2013 Q2
10 quarters
|
|
183
Berkshire Hathaway Class A
BRK.A
$1.14T
| $594K | 0.08% |
3
| – | – |
2014 Q3
5 quarters
|
|
184
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $592K | 0.08% |
6,862
+2,374
| +53% | +$208K |
2013 Q2
10 quarters
|
|
|
VVC
185
DELISTED
Vectren Corporation
VVC
| $584K | 0.08% |
13,767
+110
| +0.8% | +$4.73K |
2014 Q3
5 quarters
|
|
186
Community Bank
CBU
$3.17B
| $575K | 0.08% |
14,394
+473
| +3% | +$19.2K |
2015 Q2
2 quarters
|
|
|
187
Middleby
MIDD
$4.87B
| $557K | 0.07% |
5,133
-20,506
| -80% | -$2.28M |
2013 Q2
10 quarters
|
|
188
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$84.2M
| $554K | 0.07% |
14,187
+3,773
| +36% | +$151K |
2015 Q2
2 quarters
|
|
189
Blackstone
BX
$85.1B
| $553K | 0.07% |
18,936
-677
| -3% | -$21.6K |
2014 Q2
6 quarters
|
|
190
Clorox
CLX
$10.5B
| $544K | 0.07% |
4,286
+1,154
| +37% | +$143K |
2014 Q1
7 quarters
|
|
191
Colgate-Palmolive
CL
$75B
| $541K | 0.07% |
8,174
+340
| +4% | +$22.6K |
2013 Q2
10 quarters
|
|
192
Merck
MRK
$360B
| $540K | 0.07% |
10,814
+2,373
| +28% | +$120K |
2013 Q2
10 quarters
|
|
193
Bristol-Myers Squibb
BMY
$122B
| $530K | 0.07% |
7,684
+434
| +6% | +$28.7K |
2013 Q2
10 quarters
|
|
194
Oracle
ORCL
$389B
| $527K | 0.07% |
14,333
-151
| -1% | -$5.77K |
2013 Q2
10 quarters
|
|
195
FedEx
FDX
$69.5B
| $507K | 0.07% |
3,409
+397
| +13% | +$61.4K |
2014 Q4
4 quarters
|
|
196
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.57B
| $504K | 0.07% |
23,206
+1,453
| +7% | +$32.6K |
2013 Q2
10 quarters
|
|
197
Medtronic
MDT
$121B
| $504K | 0.07% |
6,560
+588
| +10% | +$44.3K |
2013 Q3
9 quarters
|
|
|
VER
198
DELISTED
VEREIT, Inc.
VER
| $503K | 0.07% |
12,643
-2,984
| -19% | -$122K |
2013 Q2
10 quarters
|
|
199
Kinder Morgan
KMI
$76.2B
| $502K | 0.07% |
33,946
-297
| -0.9% | -$7.08K |
2013 Q2
10 quarters
|
|
200
Annaly Capital Management
NLY
$13.7B
| $501K | 0.07% |
13,268
+264
| +2% | +$10.3K |
2013 Q2
10 quarters
|
|
Similar funds
GL
TAM
SI
GP
GES
AS
QAM
BTIS
IFC Holdings's Q4 2015 Portfolio in Review
As of Q4 2015, IFC Holdings held 408 positions worth $752M, up 15% from $656M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
IFC Holdings deployed $80.5M of net new capital in Q4 2015, opening 36 new positions and adding to 233 existing holdings. Its largest new stake was Bank of New York Mellon: 72,409 shares worth $2.99M.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 72% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Allergan plc, an estimated $6.04M trimmed.
- IFC Holdings's largest Q4 2015 buy was Bank of New York Mellon: 72,409 shares worth $2.99M.
- IFC Holdings added most to Constellation Brands in Q4 2015, an estimated $5.43M increase.
- IFC Holdings's biggest Q4 2015 reduction was Allergan plc, cutting an estimated $6.04M.
- IFC Holdings fully exited First Trust NYSE Arca Biotechnology Index Fund in Q4 2015, selling an estimated $2.13M.
- IFC Holdings's ten largest holdings make up 38% of its $752M portfolio in Q4 2015.
- IFC Holdings opened 36 new positions and closed 36 in Q4 2015.
- IFC Holdings's portfolio value rose 15% quarter-over-quarter to $752M.
Based on IFC Holdings's 13F filing for Q4 2015, filed 3 Feb 2016.